Ether (ETH) price fell 1.31% within one hour to $2,478 on Oct. 14, driven by significant liquidations of bullish leveraged positions across Binance, Bybit, and OKX. Long liquidations, which close leveraged bets on rising prices, totaled $7.62 million, far exceeding the $340,000 in short liquidations. This indicates strong selling pressure on leveraged long positions, contributing to the price decline. Over 24 hours, Ether was down 0.92%, reflecting ongoing market volatility.
Ether's recent price drop to $2,478 and long liquidations totaling $7.62 million provide context for market volatility. For readers following cryptocurrency markets, here is Pluang's snapshot as of Oct 14, 2026 19:33 WIB: out of 50 major cryptocurrencies, 18 rose and 31 fell today. Notably, SXP fell sharply by 46.27% to Rp37 with a typical hold time of 94 days, contrasting with BAL's 11.14% rise to Rp16,297 and EOS's 8.13% gain to Rp12,649, both held around 85-87 days on Pluang.
Transmission System Operators (TSOs) are increasingly investing in software like Energy Management Systems and grid planning tools to modernize aging infrastructure, enhance cybersecurity, and expand grid capacity. Cybersecurity remains their top con...
Air Canada will begin a new seasonal nonstop flight service between Montreal and Seville, Spain, starting September 8, 2027. This route is the only nonstop connection between North America and Seville, enhancing travel options for leisure and busines...
Air Canada announced it will start non-stop seasonal flights between Montréal and Seville, Spain, beginning September 8, 2027. This new route is the only direct connection between North America and Seville, enhancing travel options for Canadians and ...
CodeWall Ltd. has emerged from stealth with $4 million in pre-seed funding to develop AI-powered autonomous attack agents that simulate real-world cyberattacks on enterprises. These agents start from outside the network with no insider access, contin...
Orvida Pharma announced that the FDA has accepted its lead drug candidate KM-023 (ontivatrep) into the Rare Disease Evidence Principles (RDEP) process for treating Olmsted syndrome, a rare genetic skin disorder. This acceptance allows Orvida to engag...
